夜色资源站www国产在线资源,国产偷窥熟妇高潮呻吟,潮湿的心动漫在线观看免费未删减,欧美日韩国产成人精品

當前位置:考試網  > 試卷庫  > 公務員  > 企業事業單位考試  >  某中學女生嚴某考試時在試卷下面放著寫著公式的紙條,被監考老師發現并予沒收。考試結束后學校認為嚴某考試作弊,態度惡劣,于是對其做出勒令退學的處分決定。嚴某對處分決定不服,向校方提出申訴,但校方長時間不給予任何書面答復。閱讀以上案例,回答下列問題: 1.本案中所涉及的法律關系主體有哪些?要求:分析準確,條理清晰,字數200字左右。 2.當事人違反了什么法律?應當承擔什么責任? 3.本案對你有哪些啟示?
試題預覽

某中學女生嚴某考試時在試卷下面放著寫著公式的紙條,被監考老師發現并予沒收。考試結束后學校認為嚴某考試作弊,態度惡劣,于是對其做出勒令退學的處分決定。嚴某對處分決定不服,向校方提出申訴,但校方長時間不給予任何書面答復。閱讀以上案例,回答下列問題:

1.本案中所涉及的法律關系主體有哪些?要求:分析準確,條理清晰,字數200字左右。

2.當事人違反了什么法律?應當承擔什么責任?

3.本案對你有哪些啟示?

查看答案
收藏
糾錯
正確答案:

1、本案中所涉及的法律關系主體主要有學校和學生。學生是能動的主體,具有思想感情的個體和獨特的創造價值,是處于人生中身心發展最迅速時期的人,具有發展的可能性與可塑性。對于學生來說,身心各個方面都潛藏著極大的發展可能性,在他們身心發展過程中所展現出來的各種特征都還處在變化之中,具有極大的可塑性。同時可能性與可塑性轉變為現實的條件是個體與環境的相互作用。

2、本案是一起學校侵犯學生受教育權案。學校應承擔相應的行政法律責任。①《普通高等學校學生管理規定》中明確規定:“學生嚴重違反考核紀律或者作弊的,該課程考核成績記為無效,并由學校視其違紀或者作弊情節,給予批評教育和相應的紀律處分。”本案中,嚴某因違反了考試紀律,學校應根據其違紀程度給予其相應的紀律處分。②《憲法》中明確規定:“中華人民共和國公民有受教育的權利和義務。”據此,學校對嚴某的紀律處分應當適宜,而不應隨意剝奪嚴某作為公民的受教育權,不得隨意開除嚴某。③《教育法》中明確規定:“受教育者享有下列權利:……(四)對學校給予的處分不服向有關部門提起申訴,對學校、教師侵犯其人身權、財產權等合法權益,提出申訴或者依法提起訴訟。”據此,嚴某向學校提出申訴是合法的,學校應及時受理學生的申述。

3、啟示:①學生應加強自身的道德修養,誠實守信,自律自愛,嚴格遵守學校的規章制度與考試紀律,堅決抵制考試作弊行為。②學校應積極維護考場紀律,依法對考試違紀或作弊行為進行相應懲處。③學校應正當行使自身的權利,依法保障學生的受教育權,對學生的紀律處分應證據確鑿,恰如其分,依法進行,不得隨意開除學生,剝奪學生的受教育權。受教育權是學生最主要的權利。受教育權是中國公民所享有的并由國家保障實現的接受教育的權利,是憲法賦予的一項基本權利,也是公民享受其他文化教育的前提和基礎。就是指公民享有從國家接受文化教育的機會和獲得受教育的物質幫助的權利。受教育權包括兩個基本要素:一是公民均有上學接受教育的權利;二是國家提供教育設施,培養教師,為公民受教育創造必要機會和物質條件。相關責任人應對自身的侵權行為承擔相應的行政法律責任。④當學生的合法權利受到侵害時,應正確運用法律武器,維護自身的合法權利。⑤學校應遵守相關的法律程序,及時受理學生的申訴。

答案解析:

暫無解析

你可能感興趣的試題

根據《立法法》的規定,省、自治區、直轄市的人民代表大會常務委員會制定的地方性法規由常務委員會發布公告予以公布。()

犯罪分子危害社會,傷害他人,所以不應該給予他們以人道的待遇

按照新修訂的《行政訴訟法》,證據包括但不限于以下種類:()

行政機關可以成為行政訴訟的原告。

社會主義公民道德建設應該把道德教育與社會管理結合起來

熱門試題 更多>
試題分類: 特種設備作業
練習次數:0次
試題分類: 安全保護服務人員
練習次數:0次
試題分類: 理論與實務
練習次數:0次
1.The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels.But many researchers remain confident that drugs to boost levels of 'good' cholesterol are still one of the most promising means to combat spiralling heart disease. 2.Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib,a drug designed to raise heart-protective high-density lipoproteins (HDLs).In a trial of 15000 patients,a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone. 3.The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease."There have been no red flags to my knowledge," says John Chapman,a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib."This cancellation came as a complete shock." 4.Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs,which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body.Specifically,torcetrapib blocks a protein called cholesterol ester transfer protein (CETP),which normally transfers the cholesterol from high-density lipoproteins to low density,plaque-promoting ones.Statins,in contrast,mainly work by lowering the 'bad' low-density lipoproteins. Under pressure 5.Researchers are now trying to work out why and how the drug backfired,something that will not become clear until the clinical details are released by Pfizer.One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients.It was thought that this mild problem would be offset by the heart benefits of the drug.But it is possible that it actually proved fatal in some patients who already suffered high blood pressure.If blood pressure is the explanation,it would actually be good news for drug developers because it suggests that the problems are specific to this compound.Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall. 6.But it is also possible that the whole idea of blocking CETP is flawed,says Moti Kashyap,who directs atherosclerosis research at the VA Medical Center in Long Beach,California.When HDLs excrete cholesterol in the liver,they actually rely on LDLs for part of this process.So inhibiting CETP,which prevents the transfer of cholesterol from HDL to LDL,might actually cause an abnormal and irreversible accumulation of cholesterol in the body."You're blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway," says Kashyap.Going up 7.Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients.But HDLs are complex and not entirely understood.One approved drug,called niacin,is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling.Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone.Scientists are also working on several other means to bump up high-density lipoproteins by,for example,introducing synthetic HDLs."The only thing we know is dead in the water is torcetrapib,not the whole idea of raising HDL," says Michael Miller,director of preventive cardiology at the University of Maryland Medical Center,Baltimore. Questions 7-13 Match torcetrapib,HDLs,statin and CETP with their functions (Questions 8-13)..Write the correct letter A,B,C or D in boxes 8-13 on your answer sheet.NB You may use any letter more than once. 7.It has been administered to over 10,000 subjects in a clinical trial. 8.It could help rid human body of cholesterol. 9.Researchers are yet to find more about it. 10.It was used to reduce the level of cholesterol. 11.According to Kashyap,it might lead to unwanted result if it's blocked. 12.It produced contradictory results in different trials. 13.It could inhibit LDLs.List of choices A.TorcetrapicB.HDLSC.StatinD.CETP
試題分類: 閱讀
練習次數:3次
試題分類: 特種設備作業
練習次數:3次
試題分類: 寫作
練習次數:0次
掃一掃,手機做題